For years, prevention sat on the periphery of private health insurance. Most funds recognised its importance, many launched programs, and some generated promising results. But prevention rarely moved beyond pilots. Cohorts were small, budgets were limited, and prevention rarely appeared as a central pillar in financial or product strategy.
That is beginning to change. Across the sector, prevention is starting to scale, and more importantly it is increasingly being linked to the financial sustainability of the system rather than positioned as a wellbeing add-on. The logic is straightforward. If chronic disease continues to rise, claims costs will follow. If insurers want to bend the cost curve, they must influence health outcomes earlier in the journey.
Prevention is therefore shifting from a peripheral initiative to a structural lever.
From Member Perk to Strategic Capability
Historically, prevention initiatives were often framed as member engagement tools. Wellness apps, activity rewards and lifestyle programs created value and improved member interaction, but they rarely shifted claims trajectories at scale.
As recently as 2022, I remember developing a business case for a large health insurer to invest in a prevention-focused acquisition. A significant part of the investment rationale centred on engagement. The belief was that if members engaged more consistently with prevention tools and programs, it would ultimately influence long-term health outcomes and claims trajectories. Even at board level, prevention was still being framed primarily through the lens of engagement rather than population health management.
Today, leading funds are connecting prevention much more directly to population health outcomes and long-term cost management. Programs targeting musculoskeletal health, cardiac risk, metabolic conditions and mental health are expanding rapidly. Virtual coaching, early detection initiatives and digital monitoring are enabling funds to reach larger cohorts and intervene earlier in the health journey.
This represents a meaningful shift. Prevention is moving from engagement strategy to health management strategy.
What Scaling Prevention Looks Like
Our 2025 PHI Innovation Report highlighted several examples where prevention is moving beyond experimentation and into scaled capability. Medibank significantly expanded enrolments in prevention programs targeting heart health, joint health and metabolic conditions. These initiatives are designed to help members stay well for longer while also reducing avoidable hospital admissions.
HCF has delivered measurable outcomes through cardiac and joint health pathways that support members before surgery becomes necessary, while also improving recovery outcomes when procedures do occur. nib has broadened prevention partnerships and digital programs that support earlier intervention across a range of health conditions, while HBF has strengthened its prevention agenda within its broader strategy by linking wellbeing initiatives more directly to claims performance and member outcomes.
While the design of these programs varies across funds, the direction of travel is consistent. Prevention is increasingly being embedded as part of the operating model rather than treated as a standalone program.
Digital Is Unlocking Scale
One of the reasons prevention struggled historically was reach. Traditional programs relied heavily on in-person engagement and small clinical cohorts, which limited their ability to influence population-level health outcomes.
Digital health platforms are changing that equation. Virtual coaching, remote monitoring, digital triage and AI-supported risk stratification allow insurers to identify risk earlier and support members continuously rather than episodically. These tools enable prevention programs to reach thousands of members simultaneously while also generating the data required to measure outcomes and refine interventions.
In this sense, digital capability is not just improving member experience. It is unlocking the ability to scale prevention in ways that were previously impossible.
Prevention and Affordability Are Converging
As prevention programs expand, the connection to affordability becomes increasingly clear. Avoided surgeries, delayed disease progression and improved recovery outcomes all influence long-term claims trajectories. Prevention does not eliminate healthcare costs, but it can materially influence when and how those costs occur.
For a system facing sustained affordability pressure, this shift matters. Prevention is one of the few levers capable of influencing long-term claims growth, which is why it is increasingly being viewed through a financial as well as clinical lens.
The ROI Challenge That Slows Prevention
There is, however, a structural challenge that continues to slow prevention investment.
The further upstream you invest in the health value chain, the longer the return on investment typically takes to materialise. Prevention programs may take years to meaningfully influence claims trajectories. That reality creates tension for insurers, providers and governments alike.
Governments face the same dynamic. Investment in prevention often struggles to compete with more immediate healthcare priorities because the benefits extend beyond political cycles. Private health insurers encounter a similar constraint. Boards and executive teams must weigh prevention investment against initiatives that deliver more immediate financial impact.
This does not make prevention less important. In fact, it reinforces its strategic significance. But it does mean scaling prevention requires leadership teams willing to take a longer-term view of value creation.
A System Slowly Learning to Look Upstream
Private health insurers have traditionally operated downstream. Claims arrive, services are reimbursed and costs are managed after the event. Prevention changes that dynamic by moving insurers upstream into earlier stages of the health journey where intervention is cheaper and outcomes are often better.
Most funds acknowledge they are still early in this transition, but the trajectory is clear. Prevention is no longer simply a side program designed to support member engagement. It is becoming a strategic capability that will shape the long-term sustainability of the system.
Where These Insights Come From
The patterns outlined above are drawn from our PHI Innovation Report, which analyses how Australia’s major funds are responding to the structural forces reshaping private health insurance. Across the research, prevention emerged as one of the most significant shifts underway in the sector, not because it is a new concept, but because it is finally beginning to scale.
Download a free copy of our PHI Innovation Report
It’s Australia’s definitive benchmark of private health insurance innovation, ranking the nation’s leading funds and revealing the strategies reshaping affordability, prevention and digital care.
Exclusively free for Innovation Insiders
Benchmark Your Fund Against the Market Leaders
If prevention is moving from pilot programs to operating model capability, the obvious question for leadership teams becomes how prepared their organisation is for that shift.
Through the PHI Innovation Lab, we work with executive teams to benchmark their fund against the market’s structural responses using the PHI FACTORS™ framework. The Lab helps leadership teams understand how their organisation compares with leading funds, identify structural gaps in areas such as prevention, digital capability and care redesign, and prioritise the innovation levers most likely to shift long-term outcomes.
The PHI Innovation Lab is valued at $10,000 and is run in limited numbers each quarter to ensure depth and focus. Prevention at scale will not be built through pilots alone. It will be built through operating model redesign.
If you would like to explore running a PHI Innovation Lab with your leadership team, register your interest below.